Cardiovascular disease is responsible for nearly one-third of all deaths globally. In 2018, global pharmaceutical company, MSD, launched “Innovating Together”–a contest to find ways to combine medicine and technology to improve healthcare. Watch how CGI’s winning entry, EVAS, a predictive cardiology prototype, uses artificial intelligence and adaptive machine learning to help healthcare professionals better predict and treat this disease. EVAS was developed in collaboration with a cardiologist team and other experts from the University of Málaga and is currently seeking funding to become a full solution.
This important initiative is part of a broad range of sustainable activities CGI is investing in to reinforce the company’s ambitious corporate social responsibility strategy.